11Aug 2023
Surgical and functional outcomes of Retzius‐sparing robotic‐assisted radical prostatectomy versus conventional robotic‐assisted radical prostatectomy in patients with biopsy‐confirmed prostate cancer. Are outcomes worth it? Systematic review and meta‐analysis

Surgical and functional outcomes of Retzius‐sparing robotic‐assisted radical prostatectomy versus conventional robotic‐assisted radical prostatectomy in patients with biopsy‐confirmed prostate cancer. Are outcomes worth it? Systematic review and meta‐analysis

Radical prostatectomy is a standard treatment for prostate cancer. Retzius‐sparing robotic‐assisted radical prostatectomy (RS‐RARP) is gaining popularity due to better functional outcomes compared to conventional robotic‐assisted radical prostatectomy (c‐RARP). A systematic review of 17 studies involving 2751 patients compared RS‐RARP to c‐RARP. RS‐RARP showed faster continence recovery rates at 1 and 3 months, and better recovery at 12 months (one safety pad group). Positive surgical margins (PSM) rates were similar between the two approaches. Potency, blood loss, length of stay, operation time, and complications were comparable. RS‐RARP is considered safe and feasible, with potential advantages in continence recovery.

  • #urology

Like

Save

Share